154 related articles for article (PubMed ID: 31277053)
21. Randomized controlled clinical study on Yiqi Liangxue Shengji prescription for intervention cardiac function of acute myocardial infarction with ischemia-reperfusion injury.
Chen C; Xia J; Feng R; Wan J; Zhou K; Lin Q; Li D
Medicine (Baltimore); 2021 Mar; 100(10):e24944. PubMed ID: 33725857
[TBL] [Abstract][Full Text] [Related]
22. [Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].
Plak M; Orliński L; Łobos M; Ciesielczyk M; Wlazeł RN; Paradowski MT
Pol Merkur Lekarski; 2010 Jun; 28(168):444-9. PubMed ID: 20642101
[TBL] [Abstract][Full Text] [Related]
23. Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial.
Ou Y; Sun SJ; Shi HM; Luo JF; Luo XP; Shen YZ; Chen YF; Fan WH; Liu HY; Shen W
Chin J Integr Med; 2020 Sep; 26(9):656-662. PubMed ID: 32572777
[TBL] [Abstract][Full Text] [Related]
24. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
[TBL] [Abstract][Full Text] [Related]
25. Cardiac troponin I for prediction of clinical outcomes and cardiac function through 3-month follow-up after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Hall TS; Hallén J; Krucoff MW; Roe MT; Brennan DM; Agewall S; Atar D; Lincoff AM
Am Heart J; 2015 Feb; 169(2):257-265.e1. PubMed ID: 25641535
[TBL] [Abstract][Full Text] [Related]
26. Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug-eluting stents--the PETITION study: a prospective, randomized, multicenter study.
Zhang Q; Wang XL; Liao ML; Hu J; Yang ZK; Ding FH; Zhang JS; Du R; Zhu TQ; Shen WF; Zhang RY
Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():762-9. PubMed ID: 25630513
[TBL] [Abstract][Full Text] [Related]
27. Periprocedural Myocardial Injury After Recanalization of Single Chronic Coronary Occlusion - A Propensity Score Analysis Comparing Long-Term Clinical Outcomes.
Jaguszewski M; Gilis-Malinowska N; Gutierrez-Chico JL; Chmielecki M; Skarzynski P; Burakowski S; Drewla P; Targonski R; Lewicki L; Dubaniewicz W; Fijalkowski M; Gruchala M; Ciecwierz D
J Invasive Cardiol; 2017 Feb; 29(2):63-67. PubMed ID: 27845873
[TBL] [Abstract][Full Text] [Related]
28. Prolonged infusion of bivalirudin after elective percutaneous coronary intervention protects against procedural myocardial injury (a COBER study)-a randomized trial.
Wu Z; Meng P; Guo Y; You W; Wu X; Ye F
Sci Rep; 2023 Apr; 13(1):6667. PubMed ID: 37095298
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
[TBL] [Abstract][Full Text] [Related]
30. Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial.
Besch G; Perrotti A; Salomon du Mont L; Puyraveau M; Ben-Said X; Baltres M; Barrucand B; Flicoteaux G; Vettoretti L; Samain E; Chocron S; Pili-Floury S
Cardiovasc Diabetol; 2018 Nov; 17(1):140. PubMed ID: 30384842
[TBL] [Abstract][Full Text] [Related]
31. Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization.
McCormick LM; Hoole SP; White PA; Read PA; Axell RG; Clarke SJ; O'Sullivan M; West NEJ; Dutka DP
JACC Cardiovasc Interv; 2015 Feb; 8(2):292-301. PubMed ID: 25700752
[TBL] [Abstract][Full Text] [Related]
32. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
[TBL] [Abstract][Full Text] [Related]
33. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
[TBL] [Abstract][Full Text] [Related]
34. Intracoronary followed by intravenous administration of the short-acting β-blocker landiolol prevents myocardial injury in the face of elective percutaneous coronary intervention.
Park H; Otani H; Noda T; Sato D; Okazaki T; Ueyama T; Iwasaka J; Yamamoto Y; Iwasaka T
Int J Cardiol; 2013 Aug; 167(4):1547-51. PubMed ID: 22608892
[TBL] [Abstract][Full Text] [Related]
35. Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
Stähli BE; Gebhard C; Duchatelle V; Cournoyer D; Petroni T; Tanguay JF; Robb S; Mann J; Guertin MC; Wright RS; L L'Allier P; Tardif JC
J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852589
[TBL] [Abstract][Full Text] [Related]
36. Incidence, predicting factors, and clinical outcomes of periprocedural myocardial infarction after percutaneous coronary intervention for chronic total occlusion in the era of new-generation drug-eluting stents.
Kim JH; Kim BK; Kim S; Ahn CM; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
Catheter Cardiovasc Interv; 2018 Sep; 92(3):477-485. PubMed ID: 29266736
[TBL] [Abstract][Full Text] [Related]
37. Nicorandil for Periprocedural Myocardial Injury in Elective Percutaneous Coronary Intervention: A Meta-Analysis of 10 Randomized Controlled Trials.
Yi B; Luo J; Jiang Y; Mo S; Xiao X; Chen X; Rong J
Angiology; 2020 Aug; 71(7):609-615. PubMed ID: 32295385
[TBL] [Abstract][Full Text] [Related]
38. Intravenous GLP-1 (7-36) amide for prevention of hyperglycemia during cardiac surgery: a randomized, double-blind, placebo-controlled study.
Kohl BA; Hammond MS; Cucchiara AJ; Ochroch EA
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):618-25. PubMed ID: 24144627
[TBL] [Abstract][Full Text] [Related]
39. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial.
Atar D; Petzelbauer P; Schwitter J; Huber K; Rensing B; Kasprzak JD; Butter C; Grip L; Hansen PR; Süselbeck T; Clemmensen PM; Marin-Galiano M; Geudelin B; Buser PT;
J Am Coll Cardiol; 2009 Feb; 53(8):720-9. PubMed ID: 19232907
[TBL] [Abstract][Full Text] [Related]
40. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
